Cerene Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 50

Employees

  • Latest Deal Type
  • Series C
  • (In Progress)

  • Latest Deal Amount
  • $30M

  • Investors
  • 10

Cerene General Information

Description

Developer of a medical device designed to treat heavy menstrual bleeding by reducing the uterine lining. The company offers an endometrial cryotherapy device using controlled cooling technology that can be administered in a physician's office without incisions or general anesthesia, enabling gynecologists to provide a minimally invasive treatment option for premenopausal women with heavy menstrual bleeding caused by benign conditions.

Contact Information

Website
www.cerene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2919 Seventh Street
  • Berkeley, CA 94710
  • United States
+1 (510)
Primary Industry
Other Devices and Supplies
Vertical(s)
Corporate Office
  • 2919 Seventh Street
  • Berkeley, CA 94710
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cerene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 20-Aug-2026 $30M In Progress Generating Revenue
8. Later Stage VC (Series B1) 29-Mar-2024 Completed Generating Revenue
7. Later Stage VC (Series B) 09-Sep-2021 Completed Generating Revenue
6. Accelerator/Incubator 24-Sep-2020 Completed Clinical Trials - General
5. Merger/Acquisition 01-Jan-2018 Cancelled Clinical Trials - General
4. Later Stage VC (Series C1) 23-Aug-2017 Completed Clinical Trials - General
3. Later Stage VC (Series C) 20-Jul-2015 Completed Clinical Trials - General
2. Early Stage VC (Series B) 02-May-2013 $9.8M $10.8M Completed Startup
1. Early Stage VC (Series A) 24-Feb-2012 $1M $1M Completed Startup
To view Cerene’s complete valuation and funding history, request access »

Cerene Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A-4
Series A-3
Series A-2 3,613,327 $0.000100 8% $0.17 $0.17 $0.17 0.89%
Series A-1 5,276,319 $0.000100 8% $0.05 $0.05 $0.05 1.31%
To view Cerene’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cerene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical device designed to treat heavy menstrual bleeding by reducing the uterine lining. The company off
Other Devices and Supplies
Berkeley, CA
50 As of 2026

Hilton Head Island, SC
 

Plymouth, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cerene Competitors (19)

One of Cerene’s 19 competitors is Vygon (uk) Ltd., a Corporation company based in Hilton Head Island, SC.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vygon (uk) Ltd. Corporation Hilton Head Island, SC
HistoSonics Private Equity-Backed Plymouth, MN
Verathon Formerly PE-Backed Bothell, WA
Alpha Omega Engineering Formerly VC-backed Nazareth, Israel
Ad-Tech Medical Instrument Formerly PE-Backed Oak Creek, WI
You’re viewing 5 of 19 competitors. Get the full list »

Cerene Patents

Cerene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021426845-A1 Cryogenic treatment device encoder Active 09-Feb-2021
AU-2021426845-A9 Cryogenic treatment device encoder Active 09-Feb-2021
AU-2021426845-B2 Cryogenic treatment device encoder Active 09-Feb-2021
CA-3200231-A1 Cryogenic treatment device encoder Pending 09-Feb-2021
EP-4247283-A1 Cryogenic treatment device encoder Active 09-Feb-2021 A61B18/00
To view Cerene’s complete patent history, request access »

Cerene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cerene Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charles & Potomac Capital Family Office Minority
Dais Partners Growth/Expansion Minority
Tullis Health Investors Growth/Expansion Minority
InnovaHealth Partners Growth/Expansion Minority
AG Hill Partners Family Office Minority
You’re viewing 5 of 10 investors. Get the full list »

Cerene FAQs

  • When was Cerene founded?

    Cerene was founded in 2009.

  • Where is Cerene headquartered?

    Cerene is headquartered in Berkeley, CA.

  • What is the size of Cerene?

    Cerene has 50 total employees.

  • What industry is Cerene in?

    Cerene’s primary industry is Other Devices and Supplies.

  • Is Cerene a private or public company?

    Cerene is a Private company.

  • What is Cerene’s current revenue?

    The current revenue for Cerene is .

  • How much funding has Cerene raised over time?

    Cerene has raised $89.8M.

  • Who are Cerene’s investors?

    Charles & Potomac Capital, Dais Partners, Tullis Health Investors, InnovaHealth Partners, and AG Hill Partners are 5 of 10 investors who have invested in Cerene.

  • Who are Cerene’s competitors?

    Vygon (uk) Ltd., HistoSonics, Verathon, Alpha Omega Engineering, and Ad-Tech Medical Instrument are some of the 19 competitors of Cerene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process